Kastelein Johannes Jacob Pieter

Affiliate at NAMS

Sold, on record
$20.8M
Dollars the filings state
Form 4 sales
6
Latest Aug 24, 2026
Form 144 notices
6
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • NAMSNewAmsterdam Pharma Co N.V.Affiliate

Sales by reason

2
Routine
0
Plan not stated
0
No plan
2
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice NAMSNotice
    Jan 5, 2026 2026

    Filed to sell 6,000 shares ($199k)

    Kastelein Johannes Jacob Pieter, Affiliate

    No 10b5-1 planFiling

  2. 2 Form 4 sale NAMSRoutine
    Jan 5, 2026 same day

    Sold 6,000 shares at $33.25 ($200k)

    Kastelein Johannes Jacob Pieter, Chief Scientific Officer

    10b5-1 planSold 7.5% of holdings ($2.6M position)73,481 shares leftFollows a Form 144Filing

  3. 3 Form 144 notice NAMSNotice
    Feb 20, 2026 +46 days

    Filed to sell 45,481 shares ($1.6M)

    Kastelein Johannes Jacob Pieter, Officer, Director

    No 10b5-1 plan0.5x usual sizeFiling

  4. 4 Form 4 sale NAMSUnusual
    Feb 20, 2026 same day

    Sold 45,481 shares at $35.31 ($1.6M)

    Kastelein Johannes Jacob Pieter, Chief Scientific Officer

    No 10b5-1 planSold 45.9% of holdings ($3.5M position)53,500 shares left0.5x usual sizeFollows a Form 144Filing

  5. 5 Form 144 notice NAMSNotice
    Mar 5, 2026 +13 days

    Filed to sell 300,000 shares ($9.4M)

    Kastelein Johannes Jacob Pieter, Affiliate

    10b5-1 plan4.1x usual sizeFiling

  6. 6 Form 4 sale NAMSUnusual
    Mar 9, 2026 +4 days

    Sold 300,000 shares at $30.30 ($9.1M)

    Kastelein Johannes Jacob Pieter, Chief Scientific Officer

    10b5-1 planSold 81.2% of holdings ($11.2M position)69,302 shares left4.1x usual sizeFollows a Form 144Filing

  7. 7 Form 144 notice NAMSNotice
    Aug 24, 2026 +168 days

    Filed to sell 125,000 shares ($3.5M)

    Kastelein Johannes Jacob Pieter, Affiliate

    10b5-1 plan1.7x usual sizeFiling

  8. 8 Form 4 sale NAMSRoutine
    Aug 24, 2026 same day

    Sold 125,000 shares at $26.91 ($3.4M)

    Kastelein Johannes Jacob Pieter, Chief Scientific Officer

    10b5-1 planSold 64.3% of holdings ($5.2M position)69,302 shares left1.7x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (12)

Form 144 notices and Form 4 sales by Kastelein Johannes Jacob Pieter
Source
Aug 24, 2026Aug 25, 2026NAMSChief Scientific OfficerForm 4 sale125,000$3.4M64.3%RoutineSEC
Aug 24, 2026Aug 24, 2026NAMSAffiliateForm 144 notice125,000$3.5MNoticeSEC
Mar 9, 2026Mar 9, 2026NAMSChief Scientific OfficerForm 4 sale300,000$9.1M81.2%UnusualSEC
Mar 5, 2026Mar 5, 2026NAMSAffiliateForm 144 notice300,000$9.4MNoticeSEC
Feb 20, 2026Feb 24, 2026NAMSChief Scientific OfficerForm 4 sale45,481$1.6M45.9%UnusualSEC
Feb 20, 2026Feb 20, 2026NAMSOfficer, DirectorForm 144 notice45,481$1.6MNoticeSEC
Jan 5, 2026Jan 7, 2026NAMSChief Scientific OfficerForm 4 sale6,000$200k7.5%RoutineSEC
Jan 5, 2026Jan 5, 2026NAMSAffiliateForm 144 notice6,000$199kNoticeSEC
Aug 25, 2025Aug 25, 2025NAMSOfficer, DirectorForm 144 notice100,000$2.5MNoticeSEC
Aug 22, 2025Aug 25, 2025NAMSChief Scientific OfficerForm 4 sale100,000$2.5M59.1%UnusualSEC
Mar 26, 2024Mar 27, 2024NAMSChief Scientific OfficerForm 4 sale190,476$4.1M100.0%UnusualSEC
Mar 26, 2024Mar 26, 2024NAMSOfficer, DirectorForm 144 notice190,476$4.1MNoticeSEC